Skip to main content
logo
Genmab A/S (CPH:GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
1,611.00
+27.50 (1.74%)
Jun 8, 2026, 4:59 PM CET

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Denmark Revenue
3.33B2.87B
Denmark Revenue Growth
15.97%23.14%
Netherlands Revenue
1.00M-
United States Revenue
180.00M131.00M
United States Revenue Growth
37.41%138.18%
Japan Revenue
213.00M122.00M
Japan Revenue Growth
74.59%1933.33%
Revenue (Total)
3.72B3.12B
Revenue (Total) Growth
19.19%30.59%

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
DARZALEX Royalties Revenue
2.44B2.02B
DARZALEX Royalties Revenue Growth
21.00%23.49%
Kesimpta Royalties Revenue
443.00M323.00M
Kesimpta Royalties Revenue Growth
37.15%48.85%
TEPEZZA Royalties Revenue
105.00M106.00M
TEPEZZA Royalties Revenue Growth
-0.94%3.92%
Other Product Royalties Revenue
111.00M69.00M
Other Product Royalties Revenue Growth
60.87%97.14%
Total Royalties Revenue
3.10B2.52B
Total Royalties Revenue Growth
23.24%26.55%
Net Product Sales
398.00M253.00M
Net Product Sales Growth
57.31%314.75%
Reimbursement Revenue
53.00M144.00M
Reimbursement Revenue Growth
-63.19%16.13%
Milestone Revenue
97.00M145.00M
Milestone Revenue Growth
-33.10%-15.20%
Collaboration Revenue
70.00M62.00M
Collaboration Revenue Growth
12.90%37.78%
Revenue (Other)
-3.10B-2.52B
Revenue (Total)
3.72B3.12B
Revenue (Total) Growth
19.19%30.59%

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
J&J Revenue
2.57B2.09B
J&J Revenue Growth
22.67%20.59%
AbbVie Revenue
66.00M58.00M
AbbVie Revenue Growth
13.79%-45.28%
Roche Revenue
106.00M107.00M
Roche Revenue Growth
-0.94%4.90%
Novartis Revenue
446.00M408.00M
Novartis Revenue Growth
9.31%86.30%
BioNTech Revenue
40.00M127.00M
BioNTech Revenue Growth
-68.50%11.40%
Pfizer Revenue
77.00M77.00M
Pfizer Revenue Growth
-42.59%
Other Collaboration Partner Revenue
22.00M-
Revenue (Total)
3.72B3.12B
Revenue (Total) Growth
19.19%30.59%
Updated Dec 31, 2025. Data Source: Fiscal.ai.